Categorías
-
Adhesives
6
Amines
115
Amino Acids
207
Analytical Reagents
750
Antibiotics
270
Bioactive Small Molecules
798
Aroma Chemicals
242
Biochemicals
1142
Boronic Acids
4
Buffers
104
Building Blocks
2162
Carbohydrates
191
Catalysts
117
Chiral Compounds
78
Coccus nucifera oil
0
Detergents
62
Diagnostic Raw Materials
271
Flavours and Fragrance Materials
234
Fluorinated Products
67
Furans
7
Gases in Solution
51
Grignard Reagents
31
HPLC Reagents
8
Imidazoles
18
Indoles
48
Inorganic Chemicals
357
Ion-Pair Reagents
23
Ligands
81
Organics
1628
Oxazoles
3
Peptide Reagents
99
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
65
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
885
Salts
308
Sealing Compounds
1
Sherclin
1
Solvents
132
Stains & Indicators
322
Sugars
66
Tailor-made solutions
1
Testing Standards
4
Uncategorised
22
Water Analysis
13
Ethacridine lactate (Rivanol)
(10390333 | 1837-57-6)
CAS: | 1837-57-6 |
---|---|
Fórmula molecular: | C18H23N3O5 |
Peso molecular: | 361.39 |
Disponibilidad: | En stock |
---|---|
Descargas: | | |
10390333-5g | 5g | £62.10 | |
Pedido bulk |
10390333-5g | 5g | €87.00 | |
Pedido bulk |
10390333-5g | 5g | $93.20 | |
Pedido bulk |
Ficha de datos de seguridad
Certificado de análisis
Detalle del producto
Product Code | 10390333 | ||||
Product Name | Ethacridine lactate (Rivanol) | ||||
Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 1837-57-6 | ||||
Molecular Formula | C18H23N3O5 | ||||
Molecular Weight | 361.39 | ||||
Storage Details | Ambient | ||||
Harmonised Tariff Code | 2933998090 |
Especificaciones del producto
Total impurity | ≤1.0% | ||||
Purity (HPLC) | ≥99.0% | ||||
Single Impurity | ≤0.3% | ||||
pH | 5.5-7.0 | ||||
Loss on Drying | ≤0.5% | ||||
Assay | 98.0% - 102.0% on dry basis | ||||
Sulphated Ash | 0.1% max | ||||
Appearance | Yellow crystalline powder | ||||
Residual solvent (ethanol) | ≤5000ppm |
Información de seguridad
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|